BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 33896387)

  • 1. Clinical descriptive analysis of severe
    Xie D; Xu W; You J; Yuan X; Li M; Bi X; Zhang K; Li H; Xian Y
    Bioengineered; 2021 Dec; 12(1):1264-1272. PubMed ID: 33896387
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of Metagenomic Next-Generation Sequencing to Diagnose Pneumocystis jirovecii Pneumonia in Kidney Transplantation Recipients.
    Xu J; Yu Y; Lv J; Yang S; Wu J; Chen J; Peng W
    Ann Transplant; 2021 Jun; 26():e931059. PubMed ID: 34099614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of metagenomic next-generation sequencing in the diagnosis and treatment guidance of Pneumocystis jirovecii pneumonia in renal transplant recipients.
    Zhang F; Chen J; Huang H; Deng X; Zhang W; Zeng M; Liu R; Dai L; Wan Q
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1933-1942. PubMed ID: 33880744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic effect of low-dose trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia in adult recipients of kidney transplantation: a real-world data study.
    Chen RY; Li DW; Wang JY; Zhuang SY; Wu HY; Wu JJ; Qu JW; Sun N; Zhong C; Zhu C; Zhang M; Yu YT; Yuan XD
    Int J Infect Dis; 2022 Dec; 125():209-215. PubMed ID: 36243280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of caspofungin and low-dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients.
    Tu GW; Ju MJ; Xu M; Rong RM; He YZ; Xue ZG; Zhu TY; Luo Z
    Nephrology (Carlton); 2013 Nov; 18(11):736-42. PubMed ID: 24571744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and diagnostic value of metagenomic next -generation sequencing in five cases of non-HIV related
    Niu J; Wang J; Jia P; Zhang M; Wei E
    Front Cell Infect Microbiol; 2023; 13():1132472. PubMed ID: 37009508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk factor analysis and treatment experience in pneumocystis jirovecii pneumonia after kidney transplantation.
    Yang P; Zhu X; Liang W; Cai R
    Mycoses; 2021 May; 64(5):495-502. PubMed ID: 33368732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-center retrospective analysis of Pneumocystis jirovecii pneumonia in patients after deceased donor renal transplantation.
    Zou J; Wang T; Qiu T; Zhou J; Chen Z; Ma X; Jin Z; Xu Y; Zhang L
    Transpl Immunol; 2022 Jun; 72():101593. PubMed ID: 35367619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation.
    Werbel WA; Ison MG; Angarone MP; Yang A; Stosor V
    Transpl Infect Dis; 2018 Jun; 20(3):e12876. PubMed ID: 29512868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of trimethoprim-sulfamethoxazole as Pneumocystis jiroveci pneumonia prophylaxis on the occurrence of asymptomatic bacteriuria and urinary tract infections among renal allograft recipients: a retrospective before-after study.
    Singh R; Bemelman FJ; Hodiamont CJ; Idu MM; Ten Berge IJ; Geerlings SE
    BMC Infect Dis; 2016 Feb; 16():90. PubMed ID: 26912326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic value of metagenomic next-generation sequencing for identifying
    Zhao M; Yue R; Wu X; Gao Z; He M; Pan L
    Front Cell Infect Microbiol; 2022; 12():1026739. PubMed ID: 36389151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dapsone safety in hematology patients: Pathways to optimizing Pneumocystis jirovecii pneumonia prophylaxis in hematology malignancy and transplant recipients.
    Urbancic KF; Pisasale D; Wight J; Trubiano JA
    Transpl Infect Dis; 2018 Dec; 20(6):e12968. PubMed ID: 30030892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Veno-Venous Extracorporeal Membrane Oxygenation for Severe Pneumocystis jirovecii Pneumonia in an Immunocompromised Patient without HIV Infection.
    Nureki SI; Usagawa Y; Watanabe E; Takenaka R; Shigemitsu O; Abe T; Yasuda N; Goto K; Kitano T; Kadota JI
    Tohoku J Exp Med; 2020 Apr; 250(4):215-221. PubMed ID: 32249237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors associated with Pneumocystis jirovecii pneumonia in non-HIV immunocompromised patients and co-pathogens analysis by metagenomic next-generation sequencing.
    Huang L; Xu S; Huang Z; Chen Y; Xu N; Xie B
    BMC Pulm Med; 2023 Feb; 23(1):72. PubMed ID: 36829171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety evaluation of thrice weekly double strength vs daily single strength trimethoprim-sulfamethoxazole for prophylaxis of pneumocystis jirovecii pneumonia after kidney transplantation: a two year prospective cohort study.
    Yang H; Pang L; Hu X; Wang W; Xu B; Zhang X; Liu L
    J Pharm Pharm Sci; 2021; 24():220-226. PubMed ID: 33956598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switch to atovaquone and subsequent re-challenge with trimethoprim-sulfamethoxazole for Pneumocystis prophylaxis in a kidney transplant population.
    McLaughlin MM; Galal A; Richardson CL; Sutton SH; Barr VO; Patel N; Mitchell P; Stosor V
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28833985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A regimen based on the combination of trimethoprim/sulfamethoxazole with caspofungin and corticosteroids as a first-line therapy for patients with severe non-HIV-related pneumocystis jirovecii pneumonia: a retrospective study in a tertiary hospital.
    Li H; Lu Y; Tian G; Wu Y; Chen T; Zhang J; Hu N; Wang X; Wang Y; Gao L; Yan J; Zhou L; Shi Q
    BMC Infect Dis; 2024 Jan; 24(1):152. PubMed ID: 38297200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
    Avino LJ; Naylor SM; Roecker AM
    Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of lung microbiota in lung transplant recipients with pneumocystis jirovecii pneumonia.
    Lian Q; Song X; Yang J; Wang L; Xu P; Wang X; Xu X; Yang B; He J; Ju C
    Respir Res; 2024 Mar; 25(1):125. PubMed ID: 38486264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Performance of BAL Metagenomic Next-Generation Sequence and Serum (1,3)-β-D-Glucan for Differential Diagnosis of
    Liu L; Yuan M; Shi Y; Su X
    Front Cell Infect Microbiol; 2021; 11():784236. PubMed ID: 35004353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.